Development of Antibody-Based Therapeutics
Springer-Verlag New York
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
| Title |
Development of Antibody-Based Therapeutics
|
|---|---|
| Published by |
Springer-Verlag New York, January 2012
|
| DOI | 10.1007/978-1-4419-5955-3 |
| ISBNs |
978-1-4419-5953-9, 978-1-4419-5955-3, 978-1-4899-9113-3
|
| Authors |
Tabrizi, Mohammad A, Bornstein, Gadi G, Klakamp, Scott L |
| Editors |
Mohammad A. Tabrizi, Gadi G. Bornstein, Scott L. Klakamp |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Mexico | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 103 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 36 | 34% |
| Student > Ph. D. Student | 22 | 21% |
| Other | 11 | 10% |
| Student > Master | 8 | 8% |
| Student > Bachelor | 8 | 8% |
| Other | 7 | 7% |
| Unknown | 14 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 24 | 23% |
| Agricultural and Biological Sciences | 21 | 20% |
| Chemistry | 13 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 8% |
| Engineering | 7 | 7% |
| Other | 16 | 15% |
| Unknown | 16 | 15% |